What is the Purpose of this Study?
Primary: 1. To assess the clinical benefits of immersive VR, including skills-based VR and distraction VR, each compared to sham VR among patients with visceral pain from a digestive tract malignancies. 2. To assess the clinical benefits of immersive skills-based VR therapy vs. immersive distraction VR therapy Secondary: 1. To investigate theoretically-determined variables associated with VR pain treatment efficacy.
Eligibility
- * Have a primary malignancy of the biliary tract, colon, liver, pancreas, peritoneum, rectum, small intestine, or stomach, with no plan for resection during the study period
- * Tumor types including, but not limited to, adenocarcinoma, squamous cell carcinoma, neuroendocrine tumors, and tumors of mesenchymal origin will be eligible
- * Have clinically significant visceral pain, measured using the standardized NIH PROMIS GI Pain Scale defined as scoring at least 5 points above the nationally normed score
- * Ability to read and write in English
Where can I participate?
- CS Cancer at Cedars-Sinai Medical Center
More about this Clinical Trial
What is the full name of this clinical trial?
IIT2021-05-SPIEGEL-VR: Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes